Erectile Dysfunction after Therapy with Metoprolol: The Hawthorne Effect
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aims: It is often assumed that β-blockers, e.g. metoprolol (METO), induce erectile dysfunction (ED) in men. However, cardiovascular diseases can also induce ED and there is also the possibility that psychological factors, such as fear of the disease and side effects of the prescribed drug, may also induce ED. Thus, it is often assumed that β-blockers induce ED in a large percentage of men, but this statement is not well validated and the role of the pharmacologic effect of METO per se on the occurrence of ED is largely unknown. To get an answer we selected 114 men (age 57 ± 4.7 years) without ED but with newly diagnosed arterial hypertension, and who could be treated with METO. Methods: METO (100 mg/day) was given as a retard formulation. The hypertensive men were randomized into 3 groups. In group 1 patients were fully informed (they knew that the drug was METO and that it might induce ED). In group 2 patients were partially informed (they knew that the drug was METO, but were not informed that it might induce ED). In group 3 patients were not informed either about the drug used or about the possible occurrence of ED. The first phase of the study lasted 60 days. After 60 days the incidence of ED was 32% in group 1, 13% in group 2, and 8% in group 3 (p < 0.01). All patients with ED entered the second, cross-over, double-blind phase of the study. METO was continued at unchanged dosage, and tadalafil (20 mg) and a placebo were given to treat ED. Results: Both treatments were equally effective. Conclusion: Prejudice about the possible occurrence, i.e. the Hawthorne effect, of ED with METO facilitates the occurrence of this side effect in hypertensive men. Since the etiology of this ED is largely psychological, it is not surprising that placebo is as effective as tadalafil in reversing this side effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849 · cited 1×
“in the occurrence of ED in hypertensive men treated with metoprolol (METO). The study was planned to test (a) whether the occurrence of ED is affected by the patient’s knowledge of this potential side effect of the drug, and (b) whether the phosphodiesterase-5 inhibitor tadalafil is better than placebo in reversing ED…”
BackgroundErectile dysfunction: a marker of silent coronary artery disease
Jackson, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl110 · Cited by 62
Cited by
The Nocebo Effect and Its Relevance for Clinical Practice
Colloca, L., & Miller, F. G. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182294a50 · Cited by 419
Levine, G. N., Steinke, E. E., Bakaeen, F. G., Bozkurt, B., Cheitlin, M. D., Conti, J. B., Foster, E., Jaarsma, T., Kloner, R. A., Lange, R. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182447787 · Cited by 328
Petrie, K. J., & Rief, W. (2019) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-102907 · Cited by 309
“Similarly, among patients who were being treated with beta blockers, those warned of sexual dysfunction side effects reported these side effects three to four times more frequently than a control group who did not receive this information (Cocco 2009).”
BackgroundFaasse, K., Gamble, G., Cundy, T., & Petrie, K. J. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001607 · Cited by 83
(2019) · doi:10.32872/cpe.v1i1.29642 · Cited by 24
Metadata
- Authors
- Cocco, G.
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2008-07-24
- Volume
- 112
- Issue
- 3
- Pages
- 174-177
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W2043060997
- Cited by
- 92
- References
- 2
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.